HomeCompareGEGYF vs MRK

GEGYF vs MRK: Dividend Comparison 2026

GEGYF yields 270.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GEGYF wins by $57.0K in total portfolio value
10 years
GEGYF
GEGYF
● Live price
270.27%
Share price
$0.74
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$113.8K
Annual income
$152.43
Full GEGYF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GEGYF vs MRK

📍 GEGYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGEGYFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GEGYF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GEGYF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GEGYF
Annual income on $10K today (after 15% tax)
$22,972.97/yr
After 10yr DRIP, annual income (after tax)
$129.57/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,198.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GEGYF + MRK for your $10,000?

GEGYF: 50%MRK: 50%
100% MRK50/50100% GEGYF
Portfolio after 10yr
$85.3K
Annual income
$4,975.28/yr
Blended yield
5.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GEGYF
No analyst data
Altman Z
-8.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GEGYF buys
0
MRK buys
0
No recent congressional trades found for GEGYF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGEGYFMRK
Forward yield270.27%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$113.8K$56.8K
Annual income after 10y$152.43$9,798.13
Total dividends collected$57.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GEGYF vs MRK ($10,000, DRIP)

YearGEGYF PortfolioGEGYF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$24,214$13,513.51$11,206$366.19+$13.0KGEGYF
2$41,199$15,290.17$12,650$502.35+$28.5KGEGYF
3$56,239$12,156.92$14,407$694.19+$41.8KGEGYF
4$67,931$7,754.75$16,585$967.82+$51.3KGEGYF
5$77,063$4,377.04$19,342$1,363.89+$57.7KGEGYF
6$84,778$2,320.31$22,913$1,947.19+$61.9KGEGYF
7$91,905$1,192.80$27,662$2,823.89+$64.2KGEGYF
8$98,943$604.24$34,159$4,173.35+$64.8KGEGYF
9$106,173$303.98$43,337$6,308.80+$62.8KGEGYF
10$113,757$152.43$56,776$9,798.13+$57.0KGEGYF

GEGYF vs MRK: Complete Analysis 2026

GEGYFStock

Genel Energy plc, through its subsidiaries, operates as an independent oil and gas exploration and production company. It operates through two segments, Production and Pre-production. The Production segment holds a 25% working interest in the Tawke PSC; 44% working interest in the Taq Taq PSC; and 30% working interest in the Sarta PSC located in the Kurdistan Region of Iraq (KRI). The Pre-Production segment holds a 40% working interest Qara Dagh PSC located in KRI; 50% working interest in Odewayne and 51% working interest in SL10B13 located in Somaliland; and 75% working interest in Lagzira in Morocco. As of December 31, 2021, the company had 63 millions of barrels (MMbbls) of proven net working interest reserves, and 104 MMbbls of proven plus probable net working interest reserves. Genel Energy plc is headquartered in London, the United Kingdom.

Full GEGYF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GEGYF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GEGYF vs SCHDGEGYF vs JEPIGEGYF vs OGEGYF vs KOGEGYF vs MAINGEGYF vs JNJGEGYF vs ABBVGEGYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.